Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes

Medicine and Dentistry

• Association 5%
• Cardiovascular System 5%
• Combination Therapy 5%
• Development 5%
• Exenatide 58%
• Follow up 5%
• Glucagon-Like Peptide-1 Agonist 23%
• Group Therapy 5%
• Heart 5%
• Heart Rate 100%
• Inpatient 17%
• Least Square Analysis 5%
• Liraglutide 23%
• Metformin Plus Pioglitazone 5%
• Metformin Plus Sitagliptin 5%
• Multivariate Analysis 5%
• Patient 5%
• Patient Characteristics 5%
• Pooled Analysis 5%
• Post-Hoc Analysis 5%
• Predictor 5%
• Therapeutic Procedure 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Exendin 4 58%
• Glucagon Like Peptide 1 Receptor Agonist 23%
• Insulin 5%
• Liraglutide 23%
• Metformin Plus Pioglitazone 5%
• Metformin Plus Sitagliptin 5%
• Randomized Clinical Trial 11%

Psychology

• Clinical Trial 5%
• Group Intervention 5%
• Groups 11%
• Insulin 5%
• Metformin 5%
• Multivariate Analysis 5%
• Patient with Type 2 Diabetes 23%
• Treatment 17%